House Bill 5480
116th Congress(2019-2020)
ALS Placebo No More Act
Introduced
Introduced in House on Dec 18, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5480
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
ALS Placebo No More Act
This bill requires the Food and Drug Administration and the National Institutes of Health to collaborate to provide all patients with ALS (amyotrophic lateral sclerosis, also referred to as Lou Gehrig's disease) with access to medicines in clinical trials.
December 18, 2019
12/19/2019
Referred to the Subcommittee on Health.
12/18/2019
Referred to the House Committee on Energy and Commerce.
12/18/2019
Introduced in House
Public Record
Record Updated
Oct 28, 2022 1:46:15 AM